Federal OSHA · osha.gov
Heavy Metals

Beryllium Medical Surveillance

Beryllium causes chronic beryllium disease (CBD), beryllium sensitization, and lung cancer; affects workers in machining, foundry/smelting, ceramics, dental labs, and aerospace/defense manufacturing.

Action Level0.1 µg/m³ (8-hr TWA)
PEL0.2 µg/m³ (8-hr TWA); STEL 2.0 µg/m³ (15-min)

General Industry

Who is covered: Employees (1) exposed at/above the AL for more than 30 days/year; (2) showing signs or symptoms of CBD or other beryllium-related health effects; (3) exposed to beryllium during an emergency; or (4) recommended for periodic surveillance in a PLHCP/physician's written opinion

Evaluation performed by: PLHCP, with the written medical report authored by a licensed physician; CBD evaluation by a CBD diagnostic center (pulmonologist/pulmonary specialist with BAL and transbronchial biopsy capability)

🩺 Baseline / Pre-Placement

Within 30 days after the employee meets an eligibility criterion, unless the employee received a beryllium medical exam within the preceding 2 years

  • Medical and work history with emphasis on past and present airborne exposure to or dermal contact with beryllium, smoking history, and any history of respiratory-system dysfunction
  • Physical examination with emphasis on the respiratory system
  • Physical examination of the skin for rashes
  • Pulmonary function tests per ATS guidelines: forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV₁)
  • Standardized BeLPT (or equivalent test) at the first examination
  • Low-dose CT scan when recommended by the PLHCP after considering exposure history and other risk factors
  • Any other test deemed appropriate by the PLHCP
🕒 Periodic / Routine

Interval-based while covered — NOT result-triggered

Schedule: At least every 2 years.

  • Medical and work history with emphasis on past and present airborne exposure to or dermal contact with beryllium, smoking history, and any history of respiratory-system dysfunction
  • Physical examination with emphasis on the respiratory system
  • Physical examination of the skin for rashes
  • Pulmonary function tests per ATS guidelines (FVC, FEV₁)
  • Standardized BeLPT (or equivalent) at least every 2 years, unless the employee is confirmed positive
  • Low-dose CT scan when recommended by the PLHCP
  • Any other test deemed appropriate by the PLHCP
🚪 Exit / Termination

At termination of employment for an employee meeting an eligibility criterion

  • Termination medical examination — required unless a beryllium medical exam was provided during the 6 months prior to termination
  • Standardized BeLPT (per exam content)
⚠ Emergency / Post-Exposure

Within 30 days after an emergency beryllium exposure, if no exam was provided within the preceding 2 years

  • Medical and work history with emphasis on past and present airborne exposure to or dermal contact with beryllium, smoking history, and any history of respiratory-system dysfunction
  • Physical examination (respiratory system, skin)
  • Pulmonary function tests (FVC, FEV₁)
  • Standardized BeLPT
  • Low-dose CT scan when recommended by the PLHCP
Abnormal results & exposure-event protocols

Abnormal Results & Exposure-Event Protocols

  • BeLPT result is abnormal or borderline (and the employee is not already confirmed positive) Follow-up BeLPT on abnormal/borderline result: Offer a follow-up BeLPT within 30 days of receiving the result. Tests: Follow-up standardized BeLPT
  • PLHCP recommends referral, or the employee presents a medical report showing a confirmed positive finding or a CBD diagnosis CBD diagnostic center referral: With the employee's authorization, the employer offers an evaluation at a CBD diagnostic center within 30 days; the center provides a written report. Tests: CBD diagnostic-center evaluation (pulmonary function testing, bronchoalveolar lavage, transbronchial biopsy as indicated)
  • Employee working at/above the AL who provides a written medical report of a confirmed positive beryllium-sensitization finding or a CBD diagnosis, OR receives a written PLHCP/physician recommendation for removal Medical Removal Protection: Remove the employee from beryllium exposure. The employer either transfers the employee to comparable work below the AL (if available and the employee is qualified or can be trained within ~1 month) or maintains the employee's base earnings, seniority, and other rights/benefits for 6 months from the time of removal, or until comparable below-AL work becomes available, whichever comes first. Tests: Continued medical surveillance per the standard during removal

Reporting Requirements

Who performs the evaluationPLHCP for the exam; a licensed physician authors the written medical report; CBD diagnostic center for CBD evaluation
Reported to employerWithin 45 days, a written medical opinion containing only the date of the exam, a statement that the exam met the standard, any recommended PPE/respirator limitations, and confirmation that the PLHCP explained the results to the employee. Any further content (exposure limitations, CBD-center referral, removal recommendation) is included ONLY with the employee's written authorization.
Reported to / for the employeeWithin 45 days, a written medical report from the licensed physician containing exam results, any detected CBD/sensitization or related condition, recommendations (respirator/PPE/exposure limits), and — if confirmed positive or CBD — a recommendation for CBD-center referral, continued surveillance, and medical removal. Employee also receives a copy of the employer opinion within 45 days; CBD-center report copy within 30 days.
Time limitsWritten medical report to the employee and written opinion to the employer within 45 days of the exam; CBD diagnostic-center report within 30 days.
Second-opinion / multi-physician reviewNo formal multiple-physician review; the CBD diagnostic-center evaluation serves as the specialist confirmation pathway.
RecordkeepingRecords maintained per 29 CFR 1910.1020 (duration of employment plus 30 years), including all licensed physicians' written medical opinions and information provided to the PLHCP.

Medical Removal Protection

Removal for a confirmed positive beryllium sensitization, a CBD diagnosis, or a written removal recommendation; benefits = comparable below-AL position OR maintained base earnings/seniority/benefits for 6 months (or until comparable work is available) — notably shorter than lead/cadmium's 18 months.

Construction

Who is covered: Employees (1) exposed at/above the AL for more than 30 days/year; (2) showing signs or symptoms of CBD or other beryllium-related health effects; (3) exposed to beryllium during an emergency; or (4) recommended for periodic surveillance in a PLHCP/physician's written opinion

Evaluation performed by: PLHCP, with the written medical report authored by a licensed physician; CBD evaluation by a CBD diagnostic center (pulmonologist/pulmonary specialist with BAL and transbronchial biopsy capability)

🩺 Baseline / Pre-Placement

Within 30 days after the employee meets an eligibility criterion, unless the employee received a beryllium medical exam within the preceding 2 years

  • Medical and work history with emphasis on past and present airborne exposure to or dermal contact with beryllium, smoking history, and any history of respiratory-system dysfunction
  • Physical examination with emphasis on the respiratory system
  • Physical examination of the skin for rashes
  • Pulmonary function tests per ATS guidelines: forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV₁)
  • Standardized BeLPT (or equivalent test) at the first examination
  • Low-dose CT scan when recommended by the PLHCP after considering exposure history and other risk factors
  • Any other test deemed appropriate by the PLHCP
🕒 Periodic / Routine

Interval-based while covered — NOT result-triggered

Schedule: At least every 2 years.

  • Medical and work history with emphasis on past and present airborne exposure to or dermal contact with beryllium, smoking history, and any history of respiratory-system dysfunction
  • Physical examination with emphasis on the respiratory system
  • Physical examination of the skin for rashes
  • Pulmonary function tests per ATS guidelines (FVC, FEV₁)
  • Standardized BeLPT (or equivalent) at least every 2 years, unless the employee is confirmed positive
  • Low-dose CT scan when recommended by the PLHCP
  • Any other test deemed appropriate by the PLHCP
🚪 Exit / Termination

At termination of employment for an employee meeting an eligibility criterion

  • Termination medical examination — required unless a beryllium medical exam was provided during the 6 months prior to termination
  • Standardized BeLPT (per exam content)
⚠ Emergency / Post-Exposure

Within 30 days after an emergency beryllium exposure, if no exam was provided within the preceding 2 years

  • Medical and work history with emphasis on past and present airborne exposure to or dermal contact with beryllium, smoking history, and any history of respiratory-system dysfunction
  • Physical examination (respiratory system, skin)
  • Pulmonary function tests (FVC, FEV₁)
  • Standardized BeLPT
  • Low-dose CT scan when recommended by the PLHCP
Abnormal results & exposure-event protocols

Abnormal Results & Exposure-Event Protocols

  • BeLPT result is abnormal or borderline (and the employee is not already confirmed positive) Follow-up BeLPT on abnormal/borderline result: Offer a follow-up BeLPT within 30 days of receiving the result. Tests: Follow-up standardized BeLPT
  • PLHCP recommends referral, or the employee presents a medical report showing a confirmed positive finding or a CBD diagnosis CBD diagnostic center referral: With the employee's authorization, the employer offers an evaluation at a CBD diagnostic center within 30 days; the center provides a written report. Tests: CBD diagnostic-center evaluation (pulmonary function testing, bronchoalveolar lavage, transbronchial biopsy as indicated)
  • Employee working at/above the AL who provides a written medical report of a confirmed positive beryllium-sensitization finding or a CBD diagnosis, OR receives a written PLHCP/physician recommendation for removal Medical Removal Protection: Remove the employee from beryllium exposure. The employer either transfers the employee to comparable work below the AL (if available and the employee is qualified or can be trained within ~1 month) or maintains the employee's base earnings, seniority, and other rights/benefits for 6 months from the time of removal, or until comparable below-AL work becomes available, whichever comes first. Tests: Continued medical surveillance per the standard during removal

Reporting Requirements

Who performs the evaluationPLHCP for the exam; a licensed physician authors the written medical report; CBD diagnostic center for CBD evaluation
Reported to employerWithin 45 days, a written medical opinion containing only the date of the exam, a statement that the exam met the standard, any recommended PPE/respirator limitations, and confirmation that the PLHCP explained the results to the employee. Any further content (exposure limitations, CBD-center referral, removal recommendation) is included ONLY with the employee's written authorization.
Reported to / for the employeeWithin 45 days, a written medical report from the licensed physician containing exam results, any detected CBD/sensitization or related condition, recommendations (respirator/PPE/exposure limits), and — if confirmed positive or CBD — a recommendation for CBD-center referral, continued surveillance, and medical removal. Employee also receives a copy of the employer opinion within 45 days; CBD-center report copy within 30 days.
Time limitsWritten medical report to the employee and written opinion to the employer within 45 days of the exam; CBD diagnostic-center report within 30 days.
Second-opinion / multi-physician reviewNo formal multiple-physician review; the CBD diagnostic-center evaluation serves as the specialist confirmation pathway.
RecordkeepingRecords maintained per 29 CFR 1910.1020 (duration of employment plus 30 years), including written medical opinions. Identical to GI 1910.1024.

Medical Removal Protection

Removal for a confirmed positive beryllium sensitization, a CBD diagnosis, or a written removal recommendation; benefits = comparable below-AL position OR maintained base earnings/seniority/benefits for 6 months (or until comparable work is available) — notably shorter than lead/cadmium's 18 months.

How this compares to Cal/OSHA: Aligned. California (5205 GI, 1535.1 construction) adopted the federal beryllium standard (1910.1024 / 1926.1124) with no substantive medical-surveillance difference: AL 0.1 µg/m³, PEL 0.2 µg/m³, STEL 2.0 µg/m³; initial within 30 days (unless exam within 2 years), biennial periodic, standardized BeLPT at first exam and every 2 years with a 30-day follow-up BeLPT on abnormal results, PFTs, and low-dose CT when recommended; CBD diagnostic-center referral pathway; and Medical Removal Protection with a 6-month benefit period (verified identical in CA 5205 and 1535.1). Note section number is 5205 (not 5203).

Occu-Med handles Beryllium surveillance end-to-end

Scheduling, exams, lab panels, physician review, removal/return determinations, and audit-ready recordkeeping — fully compliant with Federal OSHA requirements.